Edition:
United Kingdom

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

4.12USD
5:03pm GMT
Change (% chg)

$-0.03 (-0.72%)
Prev Close
$4.15
Open
$4.20
Day's High
$4.20
Day's Low
$4.06
Volume
7,679
Avg. Vol
59,831
52-wk High
$6.97
52-wk Low
$2.51

Latest Key Developments (Source: Significant Developments)

T2 Biosystems Q3 loss per share $0.45
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - T2 Biosystems Inc :T2 biosystems reports third quarter 2017 financial results and provides company update.Q3 loss per share $0.45.Sees q4 revenue $1.1 million to $1.3 million.Q3 earnings per share view $-0.49 -- Thomson Reuters I/B/E/S.Q3 revenue $1.1 million versus i/b/e/s view $1.1 million.T2 biosystems inc - ‍company reaffirms expectations regarding timeframe for fda clearance of t2bacteria panel​.T2 biosystems inc - ‍continues to prepare for commercial launch of t2bacteria panel in u.s. As early as year-end, pending market clearance by fda.​.T2 biosystems inc - ‍cash and cash equivalents as of sept 30 with additional remaining liquidity on term loan , should extend cash runway into h1 2019​.  Full Article

Japan's Canon Inc reports 19.9 pct stake in T2 Biosystems - SEC filing
Friday, 30 Sep 2016 

T2 Biosystems Inc : Japan's Canon Inc reports 19.9 pct stake in T2 Biosystems Inc as of September 21, 2016 - SEC filing . Canon says T2 Biosystems and Canon USA entered into a voting and standstill agreement and a registration rights agreement . Canon says T2 Biosystems has agreed to give Canon USA certain board designation rights . Canon says T2 Biosystems to initially appoint Seymour Liebman, an EVP at Canon USA, as a class I director on the T2 board .Canon says Canon USA beneficially owns 6 million shares of common stock of T2 Biosystems as of Sept 21.  Full Article

T2 biosystems says it has sold $39.7 million in equity financing
Tuesday, 27 Sep 2016 

T2 Biosystems Inc :Says it has sold $39.7 million in equity financing - SEC filing.  Full Article

Canon U.S.A. announces equity investment in T2 Biosystems
Thursday, 22 Sep 2016 

Canon U.S.A. <7751.T> : Canon U.S.A. announces equity investment in T2 Biosystems Inc . Has purchased approximately $40 million of T2 biosystems stock at closing market price of $6.56 in a private placement . Says investment results in Canon's ownership of approximately 19.9 percent of T2 Biosystems .Seymour Liebman , EVP, chief administrative officer and general counsel, Canon U.S.A Inc will join T2 Biosystems board of directors.  Full Article

T2 Biosystems reports Q2 loss per share $0.58
Monday, 1 Aug 2016 

T2 Biosystems Inc : T2 Biosystems reports 2016 second quarter, six month results . Q2 loss per share $0.58 . Q2 revenue $990,000 . Q2 earnings per share view $-0.56 -- Thomson Reuters I/B/E/S . Q2 revenue view $1.5 million -- Thomson Reuters I/B/E/S . T2 Biosystems Inc says continues to target closing a total of 45 hospital commitments globally during 2016 . T2 Biosystems Inc says research revenue is expected to be comparable to what was realized in Q2 of 2016 . Q3 earnings per share view $-0.54, revenue view $2.2 million -- Thomson Reuters I/B/E/S . T2 Biosystems Inc says anticipates higher product revenue in Q3 of 2016 than was realized in first and second quarters of 2016 .T2 Biosystems Inc sees total Q3 of 2016 operating expenses to be between $12.3 million and $12.8 million.  Full Article

BRIEF-T2 Biosystems Q3 loss per share $0.45

* T2 biosystems reports third quarter 2017 financial results and provides company update